Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 18Hodgkin Disease 11Lymphoma, Non-Hodgkin 4Central Nervous System Neoplasms 4Recurrence 3Glioblastoma 3Astrocytoma 3Oligodendroglioma 2Neurotoxicity Syndromes 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lymphoma, AIDS-Related 2Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Intraocular Lymphoma 1HIV Infections 1Gliosarcoma 1Glioma 1Burkitt Lymphoma 1Brain Neoplasms 1

Interventions

Radiotherapy 12Amifostine 7Cisplatin 6Etoposide 3Carboplatin 3Bevacizumab 3Radiotherapy, Intensity-Modulated 2Radiation 2Paclitaxel 2Heavy Ion Radiotherapy 2Fluorouracil 2sargramostim 1lithium sulfate 1Vincristine 1Surgical Procedures, Operative 1Steroids 1Selenomethionine 1Rituximab 1Protons 1Proton Therapy 1Procarbazine 1Physical Therapy Modalities 1Photons 1Palonosetron 1Olanzapine 1Methylprednisolone 1Methotrexate 1Mental Status and Dementia Tests 1Melatonin 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Radiation Injuries × Procarbazine × Clear all
NCT01399372 2023-07-20

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Radiation Therapy Oncology Group

Phase 2 Completed
91 enrolled 17 charts
Lymphoid

Lymphoma, Radiation Injuries, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡